Moreover, as the majority of human prostate adenocarcinomas have this mature luminal phenotype, characterized by expression of cytokeratins 8/18, AR and prostate-specific antigen (PSA), the assumption has been that the cell of origin of prostate cancer is the differentiated secretory luminal cell. Here, AR is linked to prostate cancer.